A prospective study of HLA*B-5801 genotyping in preventing allopurinol- induced severe cutaneous adverse reactions

Documenti analoghi

• HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol
  di: Hung, Shuen-Iu, et al.
  Pubblicazione: (2005)
• Genotyping HLA‐B*5801 for Allopurinol‐Induced Severe Cutaneous Adverse Reactions: An Accurate and Prompt Method
  di: Cheng, Lin, et al.
  Pubblicazione: (2015)
• Use of HLA-B*58:01 genotyping to prevent allopurinol induced severe cutaneous adverse reactions in Taiwan: national prospective cohort study
  di: Ko, Tai-Ming, et al.
  Pubblicazione: (2015)
• AB086. HLA-B*1502 and HLA-B*5801 genotyping for the prevention of severe cutaneous adverse drug reactions in a Children’s Hospital
  di: Ching, Leng Kee, et al.
  Pubblicazione: (2017)
• HLA-B*58:01 allele is strongly associated with allopurinol-induced severe cutaneous adverse reactions in a Thai population
  di: Jantararoungtong, Thawinee, et al.
  Pubblicazione: (2014)